If confirmed, treatment with semaglutide should not be restarted Gallbladder problems : Rapid weight loss can increase the risk of gallstones, which may cause right upper abdominal pain, fever, or yellowing of the skin/eyes (jaundice) Diabetic retinopathy complications : Patients with existing eye disease should be monitored closely, especially during periods of rapid improvement in blood glucose control [22] [23] Acute kidney injury : Usually associated with severe dehydration from gastrointestinal side effects Allergic reactions, though rare, can occur and may present as rash, itching, or difficulty breathing
As interest in performance-related peptides grows, education-driven, compliance-focused research remains essential
"I never was able to get to the weight I needed to be no matter what I did, no matter how much I trained," Williams said
LimSSVosTFlaxmanADDanaeiGShibuyaKAdair-RohaniHet al
Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023), and it is also approved by the EMA
doi: 10.1038/ncomms5497 70 CandidoMFMedeirosMVeronezLCBastosDOliveiraKLPezukJAet al
